| I Advice |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Internet and Businesses Online > Email Marketing > Real Estate Email Marketing: Is Your Message Falling on Deaf Ears? |
|
I Advice - Real Estate Email Marketing: Is Your Message Falling on Deaf Ears?
Are your clients getting your marketing emails? If your messages are getting eaten up by over ambitious S*P*A*M filters, woul According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product d you even know? Notice I can't even spell the word (S*P*A*M) correctly without tripping them and reducing my deliverability. ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in . From new listing announcements to your monthly e-newsletter you send to past clients, getting your email delivered is impor lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ant to you if you are marketing online. If no one reads your messages, there can be no results. So the first step is to find here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe out what percentage of your emails are currently being read. In order to find out, the emails you send need to be trackable. d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro The debate rages on about whether you can market more effectively using plain text emails (which are nothing but black and whi ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc e text, no images, no color) or HTML emails (which look just like a webpage, complete with images and color, when you open up easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi he message). The results aren't exactly conclusive and many people have strong opinions about which method works for THEM in nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically HEIR market. Just remember, nothing is set in stone on the internet. What generates a response today might not tomorrow. Em and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ il marketing is a moving target. You've got to test, test, test. In the past, my recommendation was to choose plain text ema ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ls to maximize readability AND deliverability. But the problem with using only plain text email is that it isn't trackable, s ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a it is very hard to judge the response. You don't know how many people really read your message. And although HTML email IS dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ompletely trackable in that you can see who is opening your message and who is not, it does have drawbacks as well. For start cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin rs, HTML emails tend to get caught up in S*P*A*M filters a bit more easily. But the bigger issue is whether or not your reade tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen 's email program displays the different parts of an HTML email (like the pictures and links) by default - without having to cl t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ck on something to read the message. Some current email programs, by default, do not display images in HTML emails. So when ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust our clients receive your message, there will be blank boxes in place of the images, until your client clicks to view them. Em y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products il marketing is not perfect, but when it comes to trackable emailing (which is an absolute MUST), you have two options: HTML e . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ail or a plain text "teaser" ("I've just posted a new issue of my newsletter. Follow the link to read it.") leading to a "web elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip fied" version of your message. The smart thing to do is to test both and see which generates a higher response in your market tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:5 Ways to Constantly Attract Good People Tips on How to Handle Conflict in the Workplace 8 Surefire Ways To Lose Subscribers From Your Email List
|